share_log

Phoenix Rising Companies Announces Morpheus Robotics Acquisition Progress and Dental Implant Product Developments

Phoenix Rising Companies Announces Morpheus Robotics Acquisition Progress and Dental Implant Product Developments

菲尼克斯瑞星公司宣布收购Morpheus Robotics公司的进展和牙科植入物产品开发
Accesswire ·  2022/10/13 11:10

PARK CITY, UT / ACCESSWIRE / October 13, 2022 / Phoenix Rising Companies OTCMarkets PINK:PRCX:

德克萨斯州帕克城/ACCESSWIRE/2022年10月13日/凤凰城新兴公司场外交易市场粉色:PRCX:

DS Chang, CEO and Chairman of the company is pleased to announce progress towards the previously announced planned acquisition of Morpheus Robotics, Inc. Morpheus was originated and has continuing operations in Italy.

该公司首席执行官兼董事长DS Chang高兴地宣布,先前宣布的收购Morpheus Robotics,Inc.的计划取得了进展。Morpheus最初是Morpheus Robotics公司,目前继续在意大利开展业务。

While in the current pre-financing stage DS Chang continues to work with Massimo Strada and Stephen Lee of Morpheus. The Morpheus team has kept DS and Phoenix informed of ongoing advances in Morpheus product development.

在目前的前期融资阶段,DS Chang继续与Morpheus的Massimo Strada和Stephen Lee合作。Morpheus团队一直向DS和Phoenix通报Morpheus产品开发的持续进展。

The product of greatest interest currently is Morpheus' robotic devices for dental implantation. These machines, when finished and deployed, will aid oral surgeons to implant replacement teeth in patients with highly improve accuracy, greatly reducing both complications and pain. Further, use of the Morpheus machinery saves time and money.

目前最受关注的产品是Morpheus用于牙科种植的机器人设备。这些机器完成并部署后,将帮助口腔外科医生极大地提高准确性,为患者植入替换牙齿,极大地减少并发症和痛苦。此外,使用Morpheus机器可以节省时间和金钱。

The Parties are working to complete the Share Exchange Agreement as soon as possible to be followed by the closing between the entities.

双方正在努力尽快完成《换股协议》,以便在两个实体之间完成交易。

Further developments will be announced.

进一步的进展将另行公布。

ABOUT MORPHEUS: Morpheus Medical Robotic System is the result of an unprecedented combination of Artificial Intelligence Based Software, new generation medical imaging, holographic reality, robotic applications, pervasive sensors natively integrated, delivering a new and unique minimally invasive robotic surgery ecosystem.

关于Morpheus:Morpheus医疗机器人系统是基于人工智能的软件、新一代医学成像、全息现实、机器人应用、本地集成的无处不在的传感器前所未有地结合在一起的结果,提供了一个新的、独特的微创机器人手术生态系统。

The Morpheus Super-Calculus GPU Based Appliance is a parallel vectorial supercomputing machine able to process 40 trillion operations per second guaranteeing a fluid ultra-high definition 4X4K, ultra-fast artificial intelligence segmentation, real-time Holographic mixed reality modeling, real-time visual guidance self-alignment.

基于Morpheus Super-Calculus GPU的Appliance是一款并行向量超级计算器,能够每秒处理40万亿次运算,确保流畅的超高清4X4K、超高速人工智能分割、实时全息混合现实建模、实时视觉制导自对准。

Morpheus started with and continues to use a primary engineering team in Milan, Italy.

Morpheus最初在意大利米兰使用一支主要的工程团队,现在仍在使用。

PHOENIX COMMENTS DS Chang, CEO of Phoenix reminds readers of his prior comments, to wit, "This acquisition, if completed, represents a move towards Westernizing Phoenix with new acquisitions that offer a substantial possibility of incredible growth of the company and its stake holders"

凤凰卫视首席执行官DS Chang提醒读者他之前的评论,也就是说,如果完成这次收购,代表着凤凰城西化的一步,新的收购将为公司及其股东提供令人难以置信的增长的巨大可能性。

For information on Phoenix Rising Companies, visit .
contact ir@phoenix-cos.com

有关凤凰崛起公司的信息,请访问。
联系ir@Phoenix-Cos.com

CAUTIONARY STATEMENT

警示声明

This press release contains forward-looking statements. Known and unknown risks may cause actual future results to vary widely. The statements are based upon Management's and Advisor's current expectations, estimates and projections; are not guarantees of future performance and are subject to certain risks and uncertainties and other factors, some of which are beyond Management's control and are difficult to predict. A reader of this press release should not place undue reliance on forward-looking statements. Investors should understand investing in shares of PRCX involves a high degree of risk and should seek competent investment advice prior to purchasing shares.

本新闻稿包含前瞻性陈述。已知和未知的风险可能会导致未来的实际结果大相径庭。这些陈述是基于管理层和顾问公司目前的预期、估计和预测;不是对未来业绩的保证,受到某些风险、不确定因素和其他因素的影响,其中一些因素是管理层无法控制的,很难预测。本新闻稿的读者不应过分依赖前瞻性陈述。投资者应该明白投资PRCX的股票涉及高度风险,在购买股票之前应该寻求称职的投资建议。

SOURCE: Phoenix Rising Companies

资料来源:凤凰新秀公司


View source version on accesswire.com:
在accesswire.com上查看源代码版本:

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发